A Research Study to Look at Long-term Treatment With a Medicine Called NNC6019-0001 for People Who Have Heart Failure Due to Transthyretin Amyloidosis
Clinical trial NCT06260709 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06260709
- Sponsor
- Novo Nordisk A/S
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-20
- Primary completion
- 2028-02-29
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.